Use of PET to monitor the response of lung cancer to radiation treatment

European Journal of Nuclear Medicine

Volumn 27, Issue 7, 2000, Pages 861-866

  Erdi, Yusuf E ^a   Macapinlac, Homer ^a   Rosenzweig, Kenneth E ^a   Humm, John L ^a   Larson, Steven M ^a   Erdi, Alev K ^a   Yorke, Ellen D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Lung cancer; Positron emission tomography; Radiation therapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CASE REPORT; DIAGNOSTIC IMAGING; DRUG RESPONSE; FEMALE; HUMAN; IMAGE ANALYSIS; LUNG NON SMALL CELL CANCER; POSITRON EMISSION TOMOGRAPHY; TREATMENT OUTCOME;

EID: 0033931766     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000258     Document Type: Article

References (10)

1. 1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8-31.
2. 2. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT and fusion images preliminary prospective evaluation. Radiology 1994; 191: 371-377.
3. 3. Valk PE, Pounds TR, Tesar RD, Hopkins DM, Haseman MK. Cost effectiveness of PET imaging in clinical oncology. Nucl Med Biol 1996; 23: 737-743.
4. 4. Armstrong J, Raben A, Zelefsky M, Burt M, Liebel S, Burman C, Kutcher G, Harrison L, Hahn C, Ginsberg R, Rusch V, Kris M, Fuks Z. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung carcinoma. Radiother Oncol 1997; 44: 17-22.
5. 5. Robertson JM, Ten Haken RK, Hazuka MB, Turrisi AT, Martel MK, Pu AT, Littles JF, Martinez FJ, Francis IR, Quint LE, Lichter AS. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997; 37: 1079-1085.
6. 6. Rosenzweig K, Hanley J, Mychalczak B, Raben A, Fuks Z, Mageras G, Mah D, Ling C, Burman C, Kutcher G, Ginsberg R, Rusch V, Downey R, Bains M, Kris M, Leibel S. Final report of the 70.2 Gy dose levels of a phase I dose escalation study using three dimensional conformal radiotherapy in the treatment of inoperable lung cancer [abstract]. Int J Radiat Oncol Biol Phys 1998; 41 Suppl: 165.
7. 7. Abe Y, Matzuzawa T, Fujiwara T, Itoh M, Fukuda H, Yamaguchi K, Kubota K, Hatazawa J, Tada M, Ido T, Watanuki S. Clinical assessment of therapeutic effects on cancer using FDG and PET: Preliminary study of lung cancer. Int J Radiat Oncol Biol Phys 1990; 19: 1005-1010.
8. 8. Hebert ME, Lowe VJ, Hoffman JM, Patz EF, Anscher MS. Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: Preliminary findings. Am J Clin Oncol 1996; 19: 416-421.
9. 9. Erdi Y, Mawlawi O, Imbriaco M, Yeung H, Larson S, Humm J. Volume determination for metastatic lung lesions by adaptive PET image thresholding. Cancer 1997; 80: 2505-2509.
10. 10. Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac H, Finn R, Casilla C, Fazzari M, Srivastava N, Yeung H, Humm J, Guillem J, Downey R, Karpeh M, Cohen A, Ginsberg R. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in total lesion glycolysis. Clin Pos Img 1999; 2: 159-171.